Article
Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.
Cancer research - 1 Nov 2003
Mariatos George, Bothos John, Zacharatos Panayotis, Summers Matthew K, Scolnick Daniel M, Kittas Christos, Halazonetis Thanos D, Gorgoulis Vassilis G
Abstract excerpt
A hallmark of cancer is inactivation of cell cycle checkpoints. However, very few mutations targeting mitotic checkpoint genes have been described, and in those instances, a wild-type copy of the gene was retained. chfr is a mitotic checkpoint gene that functions in early prophase delaying chromosome condensation in response to microtubule poisons. In a panel of 53 lung carcinomas for which matched normal tissue...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
